F J Jiménez-Jiménez

951 total citations
24 papers, 620 citations indexed

About

F J Jiménez-Jiménez is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, F J Jiménez-Jiménez has authored 24 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 5 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in F J Jiménez-Jiménez's work include Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (7 papers) and Neurological and metabolic disorders (3 papers). F J Jiménez-Jiménez is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (7 papers) and Neurological and metabolic disorders (3 papers). F J Jiménez-Jiménez collaborates with scholars based in Spain and India. F J Jiménez-Jiménez's co-authors include A. Vázquez, Pedro Ruiz, F. de Bustos, M. Zurdo, M Ortı́-Pareja, J. A. Molina, J. Porta‐Etessam, M. V. Aguilar, M.C. Martínez‐Para and C. J. Mateos-Vega and has published in prestigious journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry and Journal of Neural Transmission.

In The Last Decade

F J Jiménez-Jiménez

22 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F J Jiménez-Jiménez Spain 12 298 170 160 104 101 24 620
J. A. Molina Spain 18 319 1.1× 328 1.9× 271 1.7× 265 2.5× 159 1.6× 30 954
M. Zurdo Spain 19 379 1.3× 264 1.6× 259 1.6× 211 2.0× 147 1.5× 36 976
J. R. Rapin France 14 88 0.3× 98 0.6× 129 0.8× 121 1.2× 50 0.5× 46 696
Ulm G Germany 7 514 1.7× 50 0.3× 65 0.4× 97 0.9× 55 0.5× 11 690
Hubert Flores United States 15 315 1.1× 82 0.5× 122 0.8× 163 1.6× 137 1.4× 28 723
Cristina Bonomini Italy 8 57 0.2× 97 0.6× 252 1.6× 76 0.7× 62 0.6× 13 491
Nick van Wijk Netherlands 15 155 0.5× 116 0.7× 309 1.9× 161 1.5× 15 0.1× 28 676
Fang Zhao China 15 47 0.2× 142 0.8× 138 0.9× 174 1.7× 222 2.2× 26 704
Jay J. Rubin United States 8 112 0.4× 75 0.4× 71 0.4× 112 1.1× 13 0.1× 9 455
Cindy Kersaitis Australia 12 87 0.3× 47 0.3× 154 1.0× 168 1.6× 39 0.4× 16 499

Countries citing papers authored by F J Jiménez-Jiménez

Since Specialization
Citations

This map shows the geographic impact of F J Jiménez-Jiménez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F J Jiménez-Jiménez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F J Jiménez-Jiménez more than expected).

Fields of papers citing papers by F J Jiménez-Jiménez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F J Jiménez-Jiménez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F J Jiménez-Jiménez. The network helps show where F J Jiménez-Jiménez may publish in the future.

Co-authorship network of co-authors of F J Jiménez-Jiménez

This figure shows the co-authorship network connecting the top 25 collaborators of F J Jiménez-Jiménez. A scholar is included among the top collaborators of F J Jiménez-Jiménez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F J Jiménez-Jiménez. F J Jiménez-Jiménez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alonso‐Navarro, Hortensia, et al.. (2015). Protocolo diagnóstico y terapéutico de los síndromes parkinsonianos. Medicine - Programa de Formación Médica Continuada Acreditado. 11(74). 4487–4489.
2.
Alonso‐Navarro, Hortensia, F J Jiménez-Jiménez, Elena Garcı́a-Martı́n, & José A. G. Agúndez. (2014). Genomic and Pharmacogenomic Biomarkers of Parkinson’s Disease. Current Drug Metabolism. 15(2). 129–181. 32 indexed citations
3.
Vázquez, A., et al.. (2009). “Panic attacks” in Parkinson's disease. Acta Neurologica Scandinavica. 87(1). 14–18. 51 indexed citations
4.
Pérez‐Molina, José A., F J Jiménez-Jiménez, Ángel Hernánz, et al.. (2002). Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease. Journal of Neural Transmission. 109(7-8). 1035–1044. 23 indexed citations
5.
Pérez‐Molina, José A., F J Jiménez-Jiménez, C. Vargas, et al.. (2002). Cerebrospinal fluid levels of insulin in patients with Alzheimer's disease. Acta Neurologica Scandinavica. 106(6). 347–350. 37 indexed citations
6.
Bustos, F. de, José Antonio Molina, F J Jiménez-Jiménez, et al.. (2000). Serum levels of coenzyme Q 10 in patients with Alzheimer's disease. Journal of Neural Transmission. 107(2). 233–239. 30 indexed citations
7.
Tallón-Barranco, A., et al.. (2000). Forma de comienzo respiratorio en la enfermedad de motoneurona. Revista de Neurología. 30(1). 51–51. 2 indexed citations
8.
Meseguer, I., J. A. Molina, F J Jiménez-Jiménez, et al.. (1999). Cerebrospinal fluid levels of selenium in patients with Alzheimer's disease. Journal of Neural Transmission. 106(3-4). 309–315. 41 indexed citations
9.
Jiménez-Jiménez, F J, Lucía Ayuso‐Peralta, J. A. Molina, & Francisco Cabrera‐Valdivia. (1999). ¿Influyen los antioxidantes de la dieta en el riesgo para desarrollar enfermedad de Parkinson?. Revista de Neurología. 29(8). 741–741. 2 indexed citations
10.
Bustos, F. de, Julián Benito‐León, F J Jiménez-Jiménez, et al.. (1999). Factores prooxidantes y antioxidantes séricos y riesgo para enfermedad de Parkinson: estudio poblacional. Revista de Neurología. 29(1). 12–12. 8 indexed citations
11.
Jiménez-Jiménez, F J, J. A. Molina, & M Ortı́-Pareja. (1999). Mecanismos farmacológicos del tratamiento de las discinesias en la enfermedad de Parkinson. Revista de Neurología. 28(9). 889–889. 1 indexed citations
12.
Pérez‐Molina, José A., et al.. (1998). In vivo proton magnetic resonance spectroscopy in patients with neuroacanthocytosis. Parkinsonism & Related Disorders. 4(1). 11–15. 2 indexed citations
13.
Molina, J. A., F J Jiménez-Jiménez, M. V. Aguilar, et al.. (1998). Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. Journal of Neural Transmission. 105(4). 479–479. 142 indexed citations
14.
Tallón-Barranco, A., et al.. (1998). Síndrome de Brown-Séquard como primera manifestación clínica de esclerosis múltiple. Revista de Neurología. 27(159). 836–836. 1 indexed citations
15.
Jiménez-Jiménez, F J & J. A. Molina. (1997). [Pharmacological therapy of complicated Parkinson's disease].. PubMed. 25 Suppl 2. S170–9. 3 indexed citations
16.
Martı́n, Miguel A., José Antonio Molina, F J Jiménez-Jiménez, et al.. (1996). Respiratory‐chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients. Neurology. 46(5). 1343–1343. 35 indexed citations
17.
Jiménez-Jiménez, F J, et al.. (1996). Drug-induced parkinsonism in a movement disorders unit: A four-year survey. Parkinsonism & Related Disorders. 2(3). 145–149. 35 indexed citations
18.
Jiménez-Jiménez, F J, José Antonio Molina, M. V. Aguilar, et al.. (1995). Serum and urinary manganese levels in patients with Parkinson's disease. Acta Neurologica Scandinavica. 91(5). 317–320. 16 indexed citations
19.
Vázquez, A., et al.. (1993). "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy.. PubMed. 87(1). 14–8. 121 indexed citations
20.
Jiménez-Jiménez, F J, et al.. (1991). [Parkinson's disease and epilepsy].. PubMed. 147(3). 244–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026